Cargando…
Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
SIMPLE SUMMARY: Head and neck cancer remains a significant burden on patients and global health systems. Traditional approaches to therapy have included surgery, and more recently radiation and chemotherapies. Targeted immunotherapies are making significant inroads into improved outcomes, but only f...
Autores principales: | Kordbacheh, Farzaneh, Farah, Camile S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307423/ https://www.ncbi.nlm.nih.gov/pubmed/34298667 http://dx.doi.org/10.3390/cancers13143453 |
Ejemplares similares
-
Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
por: Kordbacheh, Farzaneh, et al.
Publicado: (2021) -
Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
por: Major, Aidan G., et al.
Publicado: (2013) -
Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling
por: Aminuddin, Amnani, et al.
Publicado: (2016) -
Molecular landscape of head and neck cancer and implications for therapy
por: Farah, Camile S.
Publicado: (2021) -
Druggable Targets of Squamous Cell Lung Cancer
por: Kim, Cheol Hyeon
Publicado: (2013)